These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21549792)
1. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain. Welte T; Xie G; Wicker JA; Whiteman MC; Li L; Rachamallu A; Barrett A; Wang T Vaccine; 2011 Jun; 29(29-30):4853-61. PubMed ID: 21549792 [TBL] [Abstract][Full Text] [Related]
2. MAVS Is Essential for Primary CD4 Luo H; Winkelmann E; Xie G; Fang R; Peng BH; Li L; Lazear HM; Paessler S; Diamond MS; Gale M; Barrett AD; Wang T J Virol; 2017 Mar; 91(6):. PubMed ID: 28077630 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of Toll-Like Receptor 7 Compromises Innate and Adaptive T Cell Responses and Host Resistance to an Attenuated West Nile Virus Infection in Old Mice. Xie G; Luo H; Pang L; Peng BH; Winkelmann E; McGruder B; Hesse J; Whiteman M; Campbell G; Milligan GN; Cong Y; Barrett AD; Wang T J Virol; 2016 Feb; 90(3):1333-44. PubMed ID: 26581984 [TBL] [Abstract][Full Text] [Related]
4. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Xie G; Welte T; Wang J; Whiteman MC; Wicker JA; Saxena V; Cong Y; Barrett AD; Wang T Vaccine; 2013 Aug; 31(38):4143-51. PubMed ID: 23845800 [TBL] [Abstract][Full Text] [Related]
5. A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells. Xie G; Luo H; Tian B; Mann B; Bao X; McBride J; Tesh R; Barrett AD; Wang T Vaccine; 2015 Feb; 33(7):869-78. PubMed ID: 25562791 [TBL] [Abstract][Full Text] [Related]
6. Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Whiteman MC; Li L; Wicker JA; Kinney RM; Huang C; Beasley DW; Chung KM; Diamond MS; Solomon T; Barrett AD Vaccine; 2010 Jan; 28(4):1075-83. PubMed ID: 19896447 [TBL] [Abstract][Full Text] [Related]
7. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the West Nile virus NS4B protein. Wicker JA; Whiteman MC; Beasley DW; Davis CT; McGee CE; Lee JC; Higgs S; Kinney RM; Huang CY; Barrett AD Virology; 2012 Apr; 426(1):22-33. PubMed ID: 22314017 [TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of MyD88-mediated cellular immune response to West Nile virus mutant strain infection. Xie G; Whiteman MC; Wicker JA; Barrett AD; Wang T J Vis Exp; 2014 Nov; (93):e52121. PubMed ID: 25489855 [TBL] [Abstract][Full Text] [Related]
10. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Wicker JA; Whiteman MC; Beasley DW; Davis CT; Zhang S; Schneider BS; Higgs S; Kinney RM; Barrett AD Virology; 2006 Jun; 349(2):245-53. PubMed ID: 16624366 [TBL] [Abstract][Full Text] [Related]
11. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model. Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA reduction of neuronal West Nile virus replication attenuates and affords a protective immune response in mice. Brostoff T; Pesavento PA; Barker CM; Kenney JL; Dietrich EA; Duggal NK; Bosco-Lauth AM; Brault AC Vaccine; 2016 Oct; 34(44):5366-5375. PubMed ID: 27637937 [TBL] [Abstract][Full Text] [Related]
13. In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model. Szentpáli-Gavallér K; Lim SM; Dencső L; Bányai K; Koraka P; Osterhaus AD; Martina BE; Bakonyi T; Bálint Á Viruses; 2016 Feb; 8(2):. PubMed ID: 26907325 [TBL] [Abstract][Full Text] [Related]
14. Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis. Uhrlaub JL; Brien JD; Widman DG; Mason PW; Nikolich-Zugich J J Immunol; 2011 Apr; 186(7):3882-91. PubMed ID: 21339368 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of Tissue-Specific CD8 Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS J Virol; 2018 May; 92(10):. PubMed ID: 29514902 [TBL] [Abstract][Full Text] [Related]
16. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF Virol J; 2010 Jul; 7():146. PubMed ID: 20604940 [TBL] [Abstract][Full Text] [Related]
17. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2. Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759 [TBL] [Abstract][Full Text] [Related]
18. TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidate. Xia J; Winkelmann ER; Gorder SR; Mason PW; Milligan GN J Virol; 2013 Nov; 87(22):12090-101. PubMed ID: 23986602 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge. De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens. Volz A; Lim S; Kaserer M; Lülf A; Marr L; Jany S; Deeg CA; Pijlman GP; Koraka P; Osterhaus AD; Martina BE; Sutter G Vaccine; 2016 Apr; 34(16):1915-26. PubMed ID: 26939903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]